Project Grant R01AI198900
Award Date 5/7/26
Completion Date 4/30/31
Dollars Obligated $415K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $456,500 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 2, 2026 through January 31, 2028. This R21 investigator-initiated research award supports fundamental scientific inquiry into the oligoadenylate synthetase (OAS) pathway and its role in intestinal immunity and...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The University of Texas Southwestern Medical Center $828,340 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on February 6, 2026, for a five-year project period concluding January 31, 2031. The project, titled "Regulation of HIV-1 Transcription Reactivation Potential by Transcription Factor Density and Composition," focuses on understanding the molecular...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a Project Grant award of $436,466 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 2, 2025, with a completion date of June 30, 2027. This exploratory research grant supports investigator-initiated biomedical research focused on understanding the regulatory mechanisms of the FOXN1 gene and...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $249,000 project grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded April 1, 2026, with a completion date of March 31, 2028. This project grant supports investigator-initiated biomedical research aimed at identifying conserved antiviral immune mechanisms that restrict arbovirus...
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $300,000 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on September 10, 2025, with a completion date of August 31, 2026. The research focuses on developing immune checkpoint-engineered oligodendrocytes as a novel cell-based therapeutic approach for treating multiple sclerosis (MS). The...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $661,009 Project Grant to The University of Texas Southwestern Medical Center, effective April 1, 2026, through March 31, 2031, under the Allergy and Infectious Diseases Research program (CFDA 93.855). This research initiative focuses on genetic and immunological investigation of ABCF1 (ATP-Binding Cassette Sub-Family F Member 1) in celiac disease and autoimmunity. The project will generate...
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $451,000 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 1, 2025, through June 30, 2027. This award supports the development and utilization of a humanized lung-on-a-chip model to investigate nontuberculous mycobacteria (NTM) infections in a physiologically relevant...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $498,000 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 7, 2025 through July 31, 2030. This award funds research investigating the role of fungal stimulatory RNA (FSRNA) in modulating intestinal innate immune responses and inflammation. The project employs...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Texas Medical Branch at Galveston a $520,128 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) beginning August 1, 2025, with completion scheduled for July 31, 2030. This research initiative investigates molecular mechanisms by which Ehrlichia chaffeensis, the causative agent of human monocytotropic ehrlichiosis, manipulates host cell RNA...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Texas Medical Branch at Galveston a Project Grant of $576,501 under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 1, 2025, with completion scheduled for July 31, 2030. This research project investigates the previously uncharacterized role of nucleoprotein (NP) exoribonuclease in Lassa virus (LASV) replication and fitness. The award...